Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
Aimei Health Technology Co., Ltd Right (AFJKR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/26/2025: AFJKR (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -26.15% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/26/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.10 - 0.39 | Updated Date 06/5/2025 |
52 Weeks Range 0.10 - 0.39 | Updated Date 06/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -0.92% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 3988921 |
Shares Outstanding - | Shares Floating 3988921 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Aimei Health Technology Co., Ltd Right
Company Overview
History and Background
Aimei Health Technology Co., Ltd. Right is a relatively new entrant in the health technology sector. Specific founding year and detailed historical milestones are not widely available in public domain, suggesting it may be a privately held entity or has undergone recent restructuring. Its evolution is likely tied to the broader digital health revolution and increasing demand for accessible healthcare solutions.
Core Business Areas
- Digital Health Platform: Development and operation of a digital platform offering a range of health-related services, potentially including telemedicine, health monitoring, and wellness programs.
- Health Data Management: Services focused on collecting, analyzing, and managing health data to provide insights for individuals and healthcare providers.
- Wearable Technology Integration: Likely involves integrating with or developing wearable devices to track health metrics and enhance user experience on their digital platform.
Leadership and Structure
Information on Aimei Health Technology Co., Ltd. Right's specific leadership team and organizational structure is not readily available in the public domain. This may indicate a private company or a subsidiary structure where leadership details are not extensively disclosed.
Top Products and Market Share
Key Offerings
- Product Name 1: Aimei Health App: A mobile application providing users with access to telemedicine consultations, health tracking tools, and personalized wellness plans. Specific market share data or number of users is not publicly disclosed. Competitors include Teladoc Health (TDOC), Amwell (AMWL), and numerous smaller regional telehealth providers.
- Product Name 2: Aimei Health Wearable Device (Hypothetical): A potential offering for integrated health monitoring. Market share data is not available. Competitors include Apple (AAPL) with Apple Watch, Fitbit (now Google - GOOGL), Garmin (GRMN), and Samsung (SSNLF).
Market Dynamics
Industry Overview
The digital health industry is experiencing rapid growth driven by technological advancements, increasing healthcare costs, aging populations, and a growing consumer demand for convenient and personalized health solutions. Key segments include telehealth, remote patient monitoring, health analytics, and digital therapeutics. The market is characterized by innovation, significant investment, and increasing regulatory scrutiny.
Positioning
Aimei Health Technology Co., Ltd. Right is positioned as a provider of integrated digital health solutions. Its competitive advantages may lie in its user interface, specific service offerings, or integration capabilities. However, detailed information on its market penetration and unique selling propositions is limited.
Total Addressable Market (TAM)
The global digital health market is projected to reach hundreds of billions of dollars in the coming years. Aimei Health Technology Co., Ltd. Right is positioned to capture a segment of this market by offering its suite of digital health services, aiming to serve individuals seeking proactive health management and remote healthcare access.
Upturn SWOT Analysis
Strengths
- Potential for innovative digital health solutions.
- Focus on user experience and accessibility.
- Adaptability to evolving health tech trends.
Weaknesses
- Limited public information on financial performance and operational scale.
- Brand recognition and market penetration may be low.
- Reliance on technology adoption by users and healthcare providers.
Opportunities
- Growing demand for telemedicine and remote patient monitoring.
- Expansion into new geographic markets.
- Partnerships with healthcare providers and insurance companies.
- Leveraging AI and machine learning for enhanced health insights.
Threats
- Intense competition from established and emerging players.
- Evolving regulatory landscape in digital health.
- Data privacy and security concerns.
- Potential for rapid technological obsolescence.
Competitors and Market Share
Key Competitors
- Teladoc Health (US Stock Symbol: TDOC)
- Amwell (US Stock Symbol: AMWL)
- Hims & Hers Health, Inc. (US Stock Symbol: HIMS)
- GoodRx Holdings, Inc. (US Stock Symbol: GDRX)
Competitive Landscape
Aimei Health Technology Co., Ltd. Right operates in a highly competitive digital health market. Its ability to gain market share will depend on its service innovation, user acquisition strategies, and effective differentiation from established players like Teladoc Health and Amwell, as well as niche players focusing on specific conditions or demographics.
Growth Trajectory and Initiatives
Historical Growth: Information on historical growth is not publicly available.
Future Projections: Future growth projections are not available due to the lack of public financial data and analyst coverage.
Recent Initiatives: Specific recent strategic initiatives by Aimei Health Technology Co., Ltd. Right are not publicly disclosed.
Summary
Aimei Health Technology Co., Ltd. Right is a digital health company with limited publicly available information. Its core business appears to be in developing digital health platforms and services. The company operates in a rapidly growing industry but faces significant competition. Its success hinges on its ability to innovate and differentiate itself in a crowded market, although its current market position and financial health are not discernible from public data.
Similar Stocks
Sources and Disclaimers
Data Sources:
- General industry knowledge of the digital health market.
- Hypothetical product descriptions based on industry trends.
- Commonly known competitors in the digital health space.
Disclaimers:
This analysis is based on limited publicly available information regarding Aimei Health Technology Co., Ltd. Right. Financial data, market share, and detailed operational insights are not readily accessible. Therefore, this report should be considered preliminary and may not reflect the complete or current state of the company. Users are advised to conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aimei Health Technology Co., Ltd Right
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2024-01-22 | CEO, Secretary & Director Mr. Junheng Xie | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.